A photo of Christopher Dandoy.

Member, Division of Bone Marrow Transplantation and Immune Deficiency

Assistant Professor, UC Department of Pediatrics



Board Certified

About Me


Dr. Dandoy is an assistant professor of clinical pediatrics and is a pediatric bone marrow transplant physician in the Department of Bone Marrow Transplantation and Immune Deficiency at Cincinnati Children’s Hospital Medical Center. Dr. Dandoy’s clinical focus is caring for children and young adults requiring hematopoietic stem cell transplantation. Dr. Dandoy’s research focuses are on quality improvement; patient safety; bloodstream infection prevention; patient and family outcomes; and cardiopulmonary complications, including pulmonary hypertension, after stem cell transplantation.

Dr. Dandoy is a co-editor of the recently published book, "Dandoy CE, Hilden J, Billett A, Mueller B (eds). Patient Safety and Quality in Pediatric Hematology/Oncology and Stem Cell Transplantation. 2017. Springer." Dr. Dandoy has served in several local and national leadership roles as the chair of the Certification Subcommittee in the American Society of Pediatric Hematology Oncology (ASPHO), a co-physician lead for the Solutions for Patient Safety (SPS) Pediatric Hematology-Oncology CLABSI reduction collaboration.

Additional Languages

Portuguese, Spanish

Clinical Interests

Hematopoietic stem cell transplantation for children and young adults with malignancy or hemoglobinopathies

Academic Affiliation

Assistant Professor, UC Department of Pediatrics


Cancer and Blood Diseases, Bone Marrow Transplantation BMT, Cardio-Oncology

My Education

BS: Weber State University, Ogden, UT, 2003.

MD: University of Utah, Salt Lake City, UT, 2007.

MSc: University of Cincinnati, Cincinnati, OH, 2014.

Residency: Miami Children’s Hospital, Miami, FL, 2010.

Chief Residency: Miami Children’s Hospital, Miami, FL, 2011.

Fellowship: Cincinnati Children's Hospital, Cincinnati Ohio, 2014; Quality Scholar in Healthcare Transformation, James M. Anderson Center for Health Systems Excellence, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, 2014.

Certification: Pediatrics, 2010; Pediatric Hematology Oncology, 2015.

My Publications

Complement blockade for TA-TMA: lessons learned from a large pediatric cohort treated with eculizumab. Jodele, S; Dandoy, CE; Lane, A; Laskin, BL; Laskin, B; Teusink-Cross, A; Myers, KC; Wallace, G; Nelson, AS; Nelson, A; et al. Blood. 2020; 26:S138-S138.

Interferon-complement loop in transplant-associated thrombotic microangiopathy. Jodele, S; Medvedovic, M; Luebbering, N; Chen, J; Dandoy, CE; Laskin, BL; Davies, SM. Blood Advances. 2020; 4:1166-1177.

EASIX and mortality after allogeneic stem cell transplantation. Luft, T; Benner, A; Terzer, T; Jodele, S; Dandoy, CE; Storb, R; Kordelas, L; Beelen, D; Gooley, T; Sandmaier, BM; et al. Bone Marrow Transplantation. 2020; 55:553-561.

Predictors of Loss to Follow-Up Among Pediatric and Adult Hematopoietic Cell Transplantation Survivors: A Report from the Center for International Blood and Marrow Transplant Research. Buchbinder, D; Brazauskas, R; Bo-Subait, K; Ballen, K; Parsons, S; Johns, T; Hahn, T; Sharma, A; Steinbergs, A; D'Souza, A; et al. Biology of Blood and Marrow Transplantation. 2020; 26:553-561.

Incidence, Risk Factors, and Outcomes of Patients Who Develop Mucosal Barrier Injury-Laboratory Confirmed Bloodstream Infections in the First 100 Days After Allogeneic Hematopoietic Stem Cell Transplant. Dandoy, CE; Kim, S; Chen, M; Ahn, KW; Ardura, MI; Brown, V; Chhabra, S; Diaz, MA; Dvorak, C; Farhadfar, N; et al. JAMA Network Open. 2020; 3:e1918668-e1918668.

Improving the Timeliness of Chemotherapy Administration in the Bone Marrow Transplant Unit. Bhandari, R; Orgel, E; Rushing, T; Malicse, K; Evangelista, V; Jodele, S; Dandoy, CE. Biology of Blood and Marrow Transplantation. 2020; 26:150-156.

MBI-LCBI and CLABSI: more than scrubbing the line. Dandoy, CE; Alonso, PB. Bone Marrow Transplantation. 2019; 54:1932-1939.

Pediatric and Young Adult Vulvovaginal Graft-versus-Host Disease. Cizek, SM; El-Bietar, J; Rubinstein, J; Dandoy, C; Wallace, GH; Nelson, A; Khandelwal, P; Myers, KC; Hoefgen, HR. Biology of Blood and Marrow Transplantation. 2019; 25:2408-2415.

Outcomes after bloodstream infection in hospitalized pediatric hematology/oncology and stem cell transplant patients. Dandoy, CE; Kelley, T; Gaur, AH; Nagarajan, R; Demmel, K; Alonso, PB; Guinipero, T; Savelli, S; Hakim, H; Owings, A; et al. Pediatric Blood and Cancer. 2019; 66.

Bloodstream Infection Due to Vancomycin-resistant Enterococcus Is Associated with Increased Mortality after Hematopoietic Cell Transplantation for Acute Leukemia and Myelodysplastic Syndrome: A Multicenter, Retrospective Cohort Study. Papanicolaou, GA; Ustun, C; Young, JH; Chen, M; Kim, S; Ahn, KW; Komanduri, K; Lindemans, C; Auletta, JJ; Riches, ML; et al. Clinical Infectious Diseases. 2019; 69:1771-1779.